1. Welcome to Balda
Investor presentation
August 2011
©
Balda
AG

2. Contents
! Balda Group
• Segments
• Customers
• Locations
! Key Figures for the first six months of 2011
• Group
• Segments
! Forecast
• Group
• Segments
©
Balda
AG
2

3. I. Balda Group
©
Balda
AG

4. Medical segment
! Plastic solutions for pharmaceutical, diagnostic and medical
equipmentmarket segments with the focus on the personal
health care market
! Most promising segment of Balda
! Alongside strong organic growth, Balda pursues strategic
expansion
©
Balda
AG
3 4

5. Electronic Products segment
! Headsets, camera housings and tablet computers
! The segment increased business volume substantially to
35.4million euros in 2020, operating profit negative
! The segment took a big step forward in its planned strategic
diversification with new products and new customers.
©
Balda
AG
1125

6. MobileCom segment
! Products: Components for mobile telephones, including
smartphones
! The segment did not achieve its targets in terms of both sales and
profits in 2010
! Strong price pressure and intense competition continue
! Joint venture partner sought; reported as "discontinued business
division" as of the first half of 2011
©
Balda
AG
10 6
2

7. Our customers (extract)
MobileCom Electronic Products Medical
©
Balda
AG
7

8. Locations
USA Europe Asia
Beijing China
USA Germany
Boston
Bad Oeynhausen
Morrisville Suzhou
Malaysia Ipoh
Engineering office Tool shop Production Sales office
©
Balda
AG
8

9. II. Key figures
©
Balda
AG

10. Key figures for the first six months of 2011 (I)
! Stabilisation processes and search for joint venture partners
initiated in the MobileCom segment, since prospects for a
successful restructuring are increasingly negative
! The MobileCom segment has been included in the discontinued
business division since the semi-annual report for 2011
! All in all, the performance of the Medical and Electronic Products
segments was positive
©
Balda
AG
10

11. Key figures for the first six months of
2011 (II) (Medical and Electronic Products)
! The sales of the Group rose to 28.9 million euros
(previous year: 28.1 million euros)
! The EBIT increased to 1.1 million euros
(previous year: 0.6 million euros)
! EBT at 10.4 million euros (previous year: 8.9 million euros)
©
Balda
AG
11

12. Medical segment
First six months of 2011
! Sales amounting to 16.5 million euros
(previous year: 13.1 million euros)
! Positive EBIT of 1.3 million euros
(previous year: 1.1 million euros)
! According to plan, the business picks up in the second half of
the year
©
Balda
AG
12

13. Electronic Products segment
First six months of 2011
! Sales declined slightly to 12.5 million euros
(previous year: 14.9 million euros)
! EBIT at minus 1.5 million euros, a decline by 1.0 million euros
compared to the first half of 2010
©
Balda
AG
13

14. Employees, Group, first six months of
2011 (Medical and Electronic Products)
! Balda Group employed 1,025 people as at the end of the first
half of 2011 (previous year: 1,040)
! The lower number of staff is attributable to the increase in
efficiency in the Electronic Products segment, whereas
Medical increased its number of employees slightly
! MobileCom segment: 583 employees (as at end of December
2010: 1,344 employees)
©
Balda
AG
14

15. Sound financial base (I)
! The equity base rose substantially to 749.7 million euros
(year-end 2009: 159.2 million euros)
! The equity ratio in the Group rose due to high surplus and
arevaluation of TPK shares to 92.5 percent
(year-end 2009: 63.9 per cent)
! Participation rights were converted in October 2010, and 4.7
million shares issued. This measure further strengthened the
financial position of the Group
©
Balda
AG
15

16. Sound financial base (II)
! The operating cash flow rose substantially in the first half of
2011, to 7.7 million euros
! Balda AG is almost entirely debt-free
! The inventory of liquid funds stood at 36.4 million euros as at
30 June 2011
©
Balda
AG
16

17. Asset position/Balance sheet structure
First six months of 2011
! The balance sheet total of Balda Group rose to 901.9 million
euros as at 30 June 2011 (31 December 2010: 810.5 million
euros)
! Change in the revaluation of the TPK holding is reflected inthe
balance sheet as well
! With the loss of significant influence, TPK holding is no
longerconsidered an associated company and is reported as
afinancial holding at market value
©
Balda
AG
17

18. TPK IPO in Taiwan in October 2010 (I)
! Balda holds 16.1 percent in TPK, the inventor of
transparentprojected-capacitive touch technology
! The IPO of TPK in October 2010 set the enterprise value of the
company above expectations
! Balda intends to sell its shares in TPK by the end of 2011
! If sold, the shareholders will participate in the proceeds by a
dividend payout
©
Balda
AG
18

19. TPK IPO in Taiwan in October 2010 (II)
! The TPK holding, previously reported at book value ("at
equity"), has been recorded as a financial instrument at
market value since October 2010
! The share of profits is no longer shown in the profit and loss
account: only dividend payments and profit from a possible
sale of TPK shares
! High EBT in 2010 due to the one-off impact on profit through
the revaluation of the TPK shares
©
Balda
AG
19

20. Medical segment
Acquisition plans
! The strategic growth aimed for by an acquisition would substantially
strengthen the segment and the Balda Group as a whole
! A final decision is expected to be made in the second half of 2011
! Assuming a positive vote on the acquisition by the Boards, a
definite expansion of business volume is possible by the end of 2011
! An acquisition would not depend on possible disposal of the TPK
shares, even though economic reasons speak for not excluding this
option at the outset
©
Balda
AG
20

21. III. Forecast
©
Balda
AG

22. Balda Group forecast 2011
! Balda Group (Medical and Electronic Products) expects a
sales volume of 70 to 80 million euros and a slightly positive
operating profit
©
Balda
AG
22

23. Segments
Forecast 2011
! MobileCom: Search for joint venture partners is on
(August 2011)
! Electronic Products: After sales doubled in 2010, there is a
realistic chance that the segment, with new products and
scaling effects, will reach break-even in the operative business
! Balda Medical will achieve definite double-digit growth in sales
figures in 2011 and a steadily improving operating profit (EBIT)
©
Balda
AG
23

24. Balda in 2011
! Solving the difficult situation in MobileCom segment
! Balda will grow organically in the Medical and Electronic
Products segments
! With the successful acquisition in the Medical segment or a
neighbouring sector, Balda can set the cornerstone for a
future-oriented and profitable alignment of theGroup
©
Balda
AG
24

25. Disclaimer
! This presentation includes “forward-looking statements” which are based on the
current expectations of the management of Balda. They are subject to risks and
uncertainty because they relate to events and depend on circumstances that will
occur in the future, such as, for example, developments in the mobile
communications industry, changes in technology and the ability to timely and
successfully develop new products and various other factors. Balda does not
undertake any obligation to update publicly or revise forward- looking statements
except to the extent legally required.
! This presentation is not an offer of securities for sale or a solicitation of an offer to
purchase securities in the United States or elsewhere. The shares in Balda AG (the
"Shares") may not be offered or sold in the United States or to or for the account or
benefit of U.S. persons (as such term is defined in Regulation S under the U.S.
Securities Act of 1933, as amended (the "Securities Act")) unless registered under the
Securities Act or pursuant to an exemption from such registration. The Shares have
not been and will not be registered under the Securities Act.
©
Balda
AG
25

26. Thank you for your interest!
Clas Röhl
Investor Relations
Phone: + 49 5734-922-2728
Fax: + 49 5734-922-2604
Mail: croehl@balda.de
http://www.balda.de/
©
Balda
AG